C. Hénon

发表

Outcome of Patients with Non-Small Cell Lung Cancer and Brain Metastases Treated with Checkpoint Inhibitors.

D. de Ruysscher, D. Planchard, J. Adam, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Combination treatments with immunotherapy in brain metastases patients.

L. Hendriks, J. Remon, C. Henon, 2020, Future oncology.

PARP inhibition enhances tumor cell–intrinsic immunity in ERCC1-deficient non–small cell lung cancer

A. Ashworth, A. Tutt, J. Adam, 2019, The Journal of clinical investigation.

Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19

I. Amit, F. Ginhoux, L. Zitvogel, 2020, Cell.

P2.07-005 Impact of Baseline Leptomeningeal and Brain Metastases on Immunotherapy Outcomes in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients

D. Planchard, J. Adam, J. Soria, 2017 .

Single‐agent gemcitabine in patients with advanced, pre‐treated angiosarcoma: A multicenter, retrospective study

E. Fadel, A. Cesne, O. Mir, 2022, Cancer medicine.

PBRM1 Deficiency Confers Synthetic Lethality to DNA Repair Inhibitors in Cancer

R. Margueron, Andrew Lamb, J. Choudhary, 2021, Cancer Research.

Immune responses during COVID-19 infection

F. Ginhoux, L. Zitvogel, G. Kroemer, 2020, Oncoimmunology.

Oncogenic chimeric transcription factors drive tumor-specific transcription, processing, and translation of silent genomic regions.

A. Coulon, D. Surdez, D. Loew, 2022, Molecular cell.

Long lasting major response to pembrolizumab in a thoracic malignant rhabdoid-like SMARCA4-deficient tumor.

A. Cesne, O. Mir, J. Adam, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

Desmoid-type fibromatosis: Current therapeutic strategies and future perspectives.

B. Verret, T. Assi, C. Henon, 2023, Cancer treatment reviews.

Retrospective world-wide registry on the efficacy of immune checkpoint inhibitors in alveolar soft part sarcoma: Updated results from sixty patients.

J. Blay, W. Tap, P. Rutkowski, 2021 .

Patient-reported tolerability of adverse events in phase 1 trials

X. Paoletti, J. Soria, E. Lanoy, 2017, ESMO Open.

Evolution of Patterns of Care and Outcomes in the Real-Life Setting for Patients with Metastatic GIST Treated in Three French Expert Centers over Three Decades

X. Buy, S. Mathoulin-Pélissier, M. Toulmonde, 2023, Cancers.

Single-cell multiomics profiling reveals heterogeneous transcriptional programs and microenvironment in DSRCTs

A. Marchais, J. Waterfall, N. Gruel, 2024, Cell reports. Medicine.

Vena cava leiomyosarcoma surgery results in a retrospective cohort of 41 patients from two centers.

J. Issard, C. Ngo, Axel Le Cesne, 2024, Journal of surgical oncology.